Company profile for Trio Medicines

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Trio Medicines Ltd (?Trio?) is a UK-based biopharmaceutical company founded in 2007 by Hammersmith Medicines Research (HMR) Ltd and Nobel Laureate Sir James Black, renowned for inventing ?-blockers and H2-blockers. Initially focused on developing netazepide, a gastrin/CCK2 receptor antagonist, Trio has since expanded its pipeline. The company is now advancing three additional molecules: ceclazepide, another gastrin/CCK2 recept...
Trio Medicines Ltd (?Trio?) is a UK-based biopharmaceutical company founded in 2007 by Hammersmith Medicines Research (HMR) Ltd and Nobel Laureate Sir James Black, renowned for inventing ?-blockers and H2-blockers. Initially focused on developing netazepide, a gastrin/CCK2 receptor antagonist, Trio has since expanded its pipeline. The company is now advancing three additional molecules: ceclazepide, another gastrin/CCK2 receptor antagonist; TR4, a selective ?2-adrenoceptor antagonist; and TR8, a formyl peptide receptor agonist.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
44 Cumberland Avenue, London, NW10 7EW
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty